James Chippendale
Posted by Love Hope Strength on Dec 19, 2008
James Chippendale is founder and CEO of CSI Entertainment Insurance, one of the largest entertainment and sports insurance brokers in the country. James has become a national figure as a leukemia spokesperson and survivor, and co-founder of his rock n’ roll charity Love Hope Strength Foundation. James has made over 350 media appearances, including ABC, Fox News, CNN, USA TODAY, MSNBC, Bloomberg, Good Morning America, American Way, The New York Times, and The Howard Stern Radio and TV shows. In addition, he hosts a lifestyle television segment called “Last Call with James Chippendale” that airs in Dallas on Sunday nights during the sports show “Out of Bounds” on NBC. The segment showcases an athlete, musician or celebrity’s favorite place to eat, drink, dance, play or hang with friends and family.
CSI has covered some of the world’s top events, festivals and entertainers such as Barack Obama’s Inauguration in Washington DC and Victory Party in Chicago, Lollapalooza, and Austin City Limits Music Festival in addition to large-scale concerts featuring Gwen Stefani, R.E.M., Red Hot Chili Peppers, Ludacris, George Strait, and Coldplay. The company has also provided risk management for some of the world’s top athletes including Lance Armstrong and the Discovery Channel Cycling Team.
In March of 2000 James was diagnosed with very aggressive form of Leukemia and give a 50% chance of survival and only through three rounds of intense chemotherapy, radiation and a generous bone marrow transplant from a German donor form a tiny village outside Berlin was james able to successfully beat his cancer. Inspired by his battle James launched the Love Hope Strength Foundation in 2006 with co-founder and cancer survivor Mike Peters of The Alarm, they are providing critical funding and awareness for cancer centers worldwide and register donors to the worldwide Bone Marrow Transplant database. The mission is to save lives, right now, with the advances that have already been made in cancer care. More about James.
